APHB: Holy insider secret handshakes and toxic financing, and .14 warrants and clouded recent financials. Bodes well for some of my other mysteries hanging out in dust bin land.
AVNE has uploaded reports and financials to OTC Markets and has gone from a stop sign to "current information." "Subsequent events" comment in filing suggests that a very interesting acquisition or merger is in the works:
"On June 20, 2013 the Company entered a confidential "letter of Intent" to acquire certain business, assets and intellectual properties of a Califomia medical research group. The group focuses their efforts on certain published properties and patented medical extraction processes. The Company intends to expand the licensing opportunities of the acquired assets."
Stock has had a good run over the past month but I'm still a buyer on any weakness in the teens.